comparemela.com

Latest Breaking News On - Headlands technologies - Page 2 : comparemela.com

Welltower Inc (NYSE:WELL) is Cohen & Steers Inc s 2nd Largest Position

Cohen & Steers Inc. lifted its stake in Welltower Inc. (NYSE:WELL – Free Report) by 0.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 40,846,208 shares of the real estate investment trust’s stock after purchasing an additional 77,093 shares […]

Cohen & Steers Inc Boosts Stock Position in PG&E Co (NYSE:PCG)

Cohen & Steers Inc. grew its stake in PG&E Co. (NYSE:PCG – Free Report) by 8.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 6,591,065 shares of the utilities provider’s stock after purchasing an additional 509,562 shares during the period. Cohen & […]

Insider Selling: Five9, Inc (NASDAQ:FIVN) CFO Sells 10,291 Shares of Stock

Five9, Inc. (NASDAQ:FIVN – Get Free Report) CFO Barry Zwarenstein sold 10,291 shares of Five9 stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $42.64, for a total transaction of $438,808.24. Following the completion of the transaction, the chief financial officer now directly owns 107,255 […]

Huron Consulting Group Inc (NASDAQ:HURN) Director John Mccartney Sells 1,259 Shares

Huron Consulting Group Inc. (NASDAQ:HURN – Get Free Report) Director John Mccartney sold 1,259 shares of Huron Consulting Group stock in a transaction dated Tuesday, June 11th. The shares were sold at an average price of $95.38, for a total value of $120,083.42. Following the transaction, the director now owns 57,988 shares in the company, […]

Insmed (INSM) – Investment Analysts Weekly Ratings Changes

Several analysts have recently updated their ratings and price targets for Insmed (NASDAQ: INSM): 6/7/2024 – Insmed had its price target raised by analysts at Mizuho from $36.00 to $82.00. They now have a “buy” rating on the stock. 5/31/2024 – Insmed had its price target raised by analysts at Stifel Nicolaus from $39.00 to […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.